Loss of thymic function promotes EAE relapse in anti-CD52-treated mice. | Curr Res Immunol;3: 37-41, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Loss of thymic function promotes EAE relapse in anti-CD52-treated mice.

Adegoke, Adeolu O; Lin, Jiaxin; Anderson, Colin C.

Affiliation

Adegoke AO; Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
Lin J; Alberta Diabetes and Transplant Institutes, University of Alberta, Edmonton, Alberta, Canada.
Anderson CC; Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Curr Res Immunol ; 3: 37-41, 2022.

Article in En | MEDLINE | ID: mdl-35496821

Key words

Alemtuzumab; Anti-CD52; EAE; Multiple sclerosis; Recent thymic emigrants; Thymectomy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Res Immunol Year: 2022 Document type: Article Affiliation country: Canadá Country of publication: Países Bajos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Res Immunol Year: 2022 Document type: Article Affiliation country: Canadá Country of publication: Países Bajos